B. Riley Has Lowered Expectations for Enovix (NASDAQ:ENVX) Stock Price

Enovix (NASDAQ:ENVXGet Free Report) had its price target reduced by stock analysts at B. Riley from $17.00 to $12.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. B. Riley’s price target suggests a potential upside of 79.10% from the stock’s previous close.

Several other analysts have also recently commented on ENVX. Cantor Fitzgerald reiterated an “overweight” rating and set a $30.00 price target on shares of Enovix in a research report on Thursday, February 20th. Craig Hallum lowered their price objective on Enovix from $20.00 to $18.00 and set a “buy” rating on the stock in a research note on Thursday, February 20th. JPMorgan Chase & Co. cut their target price on Enovix from $15.00 to $10.00 and set an “overweight” rating for the company in a research note on Thursday, April 24th. Finally, Benchmark lowered their price target on shares of Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research report on Tuesday, April 15th. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, Enovix presently has an average rating of “Moderate Buy” and an average price target of $18.40.

Read Our Latest Report on Enovix

Enovix Stock Performance

Shares of ENVX stock opened at $6.70 on Tuesday. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. Enovix has a 12-month low of $5.27 and a 12-month high of $18.68. The business’s 50 day moving average is $7.38 and its two-hundred day moving average is $9.43. The company has a market capitalization of $1.28 billion, a P/E ratio of -4.62 and a beta of 1.98.

Enovix (NASDAQ:ENVXGet Free Report) last announced its earnings results on Wednesday, February 19th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.01. The firm had revenue of $9.72 million for the quarter, compared to analyst estimates of $8.77 million. Enovix had a negative return on equity of 96.99% and a negative net margin of 963.17%. Analysts expect that Enovix will post -1.01 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Rajendra K. Talluri sold 300,000 shares of the stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $9.35, for a total transaction of $2,805,000.00. Following the transaction, the chief executive officer now owns 2,045,301 shares of the company’s stock, valued at approximately $19,123,564.35. This represents a 12.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 15.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Lpwm LLC acquired a new stake in Enovix during the 4th quarter worth approximately $549,000. Vanguard Group Inc. increased its position in shares of Enovix by 15.1% during the fourth quarter. Vanguard Group Inc. now owns 15,773,464 shares of the company’s stock worth $171,458,000 after acquiring an additional 2,063,631 shares during the period. Haven Private LLC purchased a new stake in shares of Enovix during the fourth quarter worth $454,000. Register Financial Advisors LLC raised its stake in shares of Enovix by 172.8% in the fourth quarter. Register Financial Advisors LLC now owns 174,850 shares of the company’s stock valued at $1,901,000 after acquiring an additional 110,750 shares in the last quarter. Finally, Amundi boosted its holdings in Enovix by 360.8% in the fourth quarter. Amundi now owns 235,369 shares of the company’s stock valued at $2,558,000 after purchasing an additional 184,294 shares during the period. Hedge funds and other institutional investors own 50.92% of the company’s stock.

About Enovix

(Get Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

See Also

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.